2-Aminoadipate has been associated with diabetes, obesity and metabolic syndrome risk in humans [75,76] and this diabetogen was also augmented in iNOS-/- mice but reverted by only pioglitazone and ampicillin-neomycin treatment. This evidence concerns the gene NOS2 and obesity disorder.